Published in Curr Opin Hematol on May 01, 2015
Bone Marrow Aspirate Concentrate Versus Triamcinolone Injection For Hip Osteoarthritis | NCT04990128
Novel insights in the management of sickle cell disease in childhood. World J Clin Pediatr (2016) 0.86
Forced chromatin looping raises fetal hemoglobin in adult sickle cells to higher levels than pharmacologic inducers. Blood (2016) 0.76
Infectious Risk Following Allogeneic Hematopoietic Cell Transplant Complicated by Acute Graft-Versus-Host Disease. Biol Blood Marrow Transplant (2016) 0.75
Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease. PLoS One (2017) 0.75
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA (2014) 5.01
Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med (2009) 4.59
HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood (2012) 2.72
HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. N Engl J Med (2014) 2.69
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood (2007) 2.36
Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype. JAMA (2014) 2.01
Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol (2007) 1.84
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant (2003) 1.81
Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood (1995) 1.72
Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood (2013) 1.68
Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant (1998) 1.57
Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. Biol Blood Marrow Transplant (2009) 1.46
Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan. Blood (2012) 1.37
Bone-marrow transplantation in a patient with sickle-cell anemia. N Engl J Med (1984) 1.32
Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. Bone Marrow Transplant (2005) 1.29
Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transplant (2008) 1.27
Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant (2011) 1.24
Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biol Blood Marrow Transplant (2012) 1.21
Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist. Blood (2014) 1.16
Barriers to bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant (1996) 1.14
Therapy preference and decision-making among patients with severe sickle cell anemia and their families. Pediatr Blood Cancer (2007) 1.02
Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis. Br J Haematol (2007) 0.96
Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease. Bone Marrow Transplant (2010) 0.94
Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transplant (2013) 0.92
Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions. Bone Marrow Transplant (2001) 0.91
Haematopoietic stem cell transplantation for severe sickle cell disease in childhood: a single centre experience of 50 patients. Br J Haematol (2014) 0.90
Stem cell transplant for children with sickle cell anemia: parent and patient interest. Biol Blood Marrow Transplant (2012) 0.88
Allogeneic transplantation strategies including haploidentical transplantation in sickle cell disease. Hematology Am Soc Hematol Educ Program (2013) 0.86
Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease. Bone Marrow Transplant (2014) 0.85
Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome. Bone Marrow Transplant (2004) 0.83
Hematopoietic SCT for the Black African and non-Black African variants of sickle cell anemia. Bone Marrow Transplant (2014) 0.80
Is there still a place for myeloablative regimen to transplant young adults with sickle cell disease? Blood (2011) 0.79
Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin. Pediatr Blood Cancer (2014) 0.78
Cerebral vascular abnormalities in pediatric patients with sickle cell disease after hematopoietic cell transplant. J Pediatr Hematol Oncol (2014) 0.78
Normalized transcranial Doppler velocities, stroke prevention and improved pulmonary function after stem cell transplantation in children with sickle cell anemia. Klin Padiatr (2013) 0.78
Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies. Pediatr Blood Cancer (2014) 0.77
[Development of psychological and intellectual performance in transplanted sickle cell disease patients: a prospective study from pretransplant period to 5 years after HSCT]. Arch Pediatr (2013) 0.77